Validation of the GATMO score in predicting non-relapse mortality following hematopoietic cell transplant in multiple myeloma patients

Eur J Haematol. 2024 Feb;112(2):314-316. doi: 10.1111/ejh.14116. Epub 2023 Oct 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disease-Free Survival
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / therapy
  • Retrospective Studies
  • Transplantation, Autologous